Riot Blockchain (NASDAQ: QTNT) and Quotient (NASDAQ:QTNT) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings and valuation.
Risk & Volatility
Riot Blockchain has a beta of 2.5, meaning that its stock price is 150% more volatile than the S&P 500. Comparatively, Quotient has a beta of 0.17, meaning that its stock price is 83% less volatile than the S&P 500.
13.4% of Riot Blockchain shares are held by institutional investors. Comparatively, 49.3% of Quotient shares are held by institutional investors. 2.7% of Riot Blockchain shares are held by insiders. Comparatively, 17.4% of Quotient shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
This table compares Riot Blockchain and Quotient’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of recent ratings and recommmendations for Riot Blockchain and Quotient, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Riot Blockchain presently has a consensus target price of $10.00, indicating a potential upside of 153.81%. Quotient has a consensus target price of $11.50, indicating a potential upside of 60.84%. Given Riot Blockchain’s higher probable upside, research analysts plainly believe Riot Blockchain is more favorable than Quotient.
Valuation and Earnings
This table compares Riot Blockchain and Quotient’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Riot Blockchain||$170,000.00||325.17||-$19.84 million||($2.71)||-1.45|
|Quotient||$24.73 million||15.65||-$82.33 million||($2.02)||-3.54|
Riot Blockchain has higher earnings, but lower revenue than Quotient. Quotient is trading at a lower price-to-earnings ratio than Riot Blockchain, indicating that it is currently the more affordable of the two stocks.
Quotient beats Riot Blockchain on 8 of the 12 factors compared between the two stocks.
Riot Blockchain Company Profile
Riot Blockchain, Inc. focuses on building, supporting, and operating blockchain technologies, primarily through its cryptocurrency mining operations and other developed businesses, as well as joint ventures, acquisitions, and targeted investments in the sector. Its primary focus is on Bitcoin and general blockchain technology. The company leverages its expertise and network to build and support blockchain technology companies. It builds a cryptocurrency mining operation and operates specialized computers that generate cryptocurrency, primarily Bitcoin. The company also holds interests in various activities, including purchasing and selling cryptocurrencies; providing accounting, audit, and verification services for blockchain based assets, such as cryptocurrencies; and developing TessPay, a payments ecosystem for component and sub-component supply chain settlements, and other blockchain solutions for telecommunications companies. As of March 31, 2018, approximately 3,500 of the miners were installed and operating. The company was formerly known as Bioptix, Inc. and changed its name to Riot Blockchain, Inc. in October 2017. Riot Blockchain, Inc. was founded in 2000 and is based in Castle Rock, Colorado.
Quotient Company Profile
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood-group antigens; reagent red blood cells, which enable the identification of blood-group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.
Receive News & Ratings for Riot Blockchain Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Riot Blockchain and related companies with MarketBeat.com's FREE daily email newsletter.